全文获取类型
收费全文 | 2650篇 |
免费 | 175篇 |
国内免费 | 50篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 109篇 |
妇产科学 | 51篇 |
基础医学 | 313篇 |
口腔科学 | 102篇 |
临床医学 | 234篇 |
内科学 | 618篇 |
皮肤病学 | 52篇 |
神经病学 | 179篇 |
特种医学 | 214篇 |
外科学 | 405篇 |
综合类 | 83篇 |
一般理论 | 1篇 |
预防医学 | 148篇 |
眼科学 | 112篇 |
药学 | 136篇 |
中国医学 | 3篇 |
肿瘤学 | 97篇 |
出版年
2021年 | 33篇 |
2020年 | 23篇 |
2019年 | 33篇 |
2018年 | 30篇 |
2017年 | 27篇 |
2016年 | 37篇 |
2015年 | 56篇 |
2014年 | 54篇 |
2013年 | 62篇 |
2012年 | 76篇 |
2011年 | 85篇 |
2010年 | 68篇 |
2009年 | 61篇 |
2008年 | 94篇 |
2007年 | 109篇 |
2006年 | 91篇 |
2005年 | 69篇 |
2004年 | 88篇 |
2003年 | 85篇 |
2002年 | 81篇 |
2001年 | 81篇 |
2000年 | 52篇 |
1999年 | 57篇 |
1998年 | 61篇 |
1997年 | 63篇 |
1996年 | 71篇 |
1995年 | 53篇 |
1994年 | 46篇 |
1993年 | 36篇 |
1992年 | 50篇 |
1991年 | 43篇 |
1990年 | 50篇 |
1989年 | 69篇 |
1988年 | 72篇 |
1987年 | 74篇 |
1986年 | 62篇 |
1985年 | 50篇 |
1984年 | 55篇 |
1983年 | 40篇 |
1982年 | 36篇 |
1981年 | 25篇 |
1980年 | 33篇 |
1979年 | 29篇 |
1978年 | 34篇 |
1977年 | 33篇 |
1975年 | 29篇 |
1974年 | 27篇 |
1973年 | 24篇 |
1972年 | 31篇 |
1968年 | 22篇 |
排序方式: 共有2875条查询结果,搜索用时 528 毫秒
71.
Ehninger G; Schuler U; Renner U; Ehrsam M; Zeller KP; Blanz J; Storb R; Deeg HJ 《Blood》1995,85(11):3247-3249
In a canine model we investigated the toxicity and pharmacokinetics of a water soluble busulfan preparation. Busulfan was dissolved in dimethylsulfoxide (DMSO) and administered either orally or intravenously in a single dose of 1 mg/kg. The application in either preparation was well tolerated. In seven dogs, peak levels in the range of 730 ng/mL to 1,000 ng/mL were measured after intravenous injection with an area under curve (AUC) of 75 ng.h/kg.mL to 146 ng.h/kg.mL. It was of note that even the oral administration of the same busulfan preparation resulted in AUC values in the same range as observed after parenteral application. The absorption rate of busulfan tablets in our model was as unpredictable as documented in clinical trials. On the basis of the present study, clinical trials using busulfan dissolved in DMSO given either intravenously or orally appear warranted. This approach should lead to predictable blood levels, reduced toxicity, and increased efficacy of busulfan-containing regimens. 相似文献
72.
Expression and function of CD40 on Hodgkin and Reed-Sternberg cells and the possible relevance for Hodgkin's disease 总被引:7,自引:2,他引:7
Gruss HJ; Hirschstein D; Wright B; Ulrich D; Caligiuri MA; Barcos M; Strockbine L; Armitage RJ; Dower SK 《Blood》1994,84(7):2305-2314
CD40 was originally described as a B-cell-restricted antigen and was subsequently found to be a member of the tumor necrosis factor (TNF) receptor superfamily. CD40 is also expressed on dendritic cells, thymic epithelium, monocytes, and some carcinoma cell lines, and plays a critical role in cell contact-dependent activation. Primary and cultured Hodgkin and Reed-Sternberg (H-RS) cells, the presumed malignant cells of Hodgkin's disease (HD); were found to express high levels of cell surface CD40. We found that recombinant CD40 ligand (CD40L) induced interleukin-8 (IL-8) secretion and enhanced IL-6, TNF, and lymphotoxin-alpha (LT-alpha/TNF-beta) release from cultured H-RS cells. These cytokines play a significant role in the clinical presentation and pathology of HD, a tumor of cytokine-producing cells. CD40L had no mitogenic activity for HD-derived cell lines. In contrast, CD40L enhanced expression of costimulatory molecules intracellular adhesion molecule-T and B7-1 on cultured H-RS cells, both of which are overexpressed on primary H-RS cells. In addition, CD40L induced a 40% to 60% reduction of the expression of the HD-associated CD30 antigen, another member of the TNF receptor superfamily. Primary and cultured H- RS cells express not only CD30, but also CD40. CD40L has pleiotropic biologic activities on H-RS cells, and the CD40-CD40L interaction might be a critical element in the deregulated cytokine network and cell contact-dependent activation cascade typical for HD. 相似文献
73.
74.
75.
Gunnar Hargus Marc Ehrlich Anna-Lena Hallmann Tanja Kuhlmann 《Acta neuropathologica》2014,127(2):151-173
The number of patients with neurodegenerative diseases is increasing significantly worldwide. Thus, intense research is being pursued to uncover mechanisms of disease development in an effort to identify molecular targets for therapeutic intervention. Analysis of postmortem tissue from patients has yielded important histological and biochemical markers of disease progression. However, this approach is inherently limited because it is not possible to study patient neurons prior to degeneration. As such, transgenic and knockout models of neurodegenerative diseases are commonly employed. While these animal models have yielded important insights into some molecular mechanisms of disease development, they do not provide the opportunity to study mechanisms of neurodegeneration in human neurons at risk and thus, it is often difficult or even impossible to replicate human pathogenesis with this approach. The generation of patient-specific induced pluripotent stem (iPS) cells offers a unique opportunity to overcome these obstacles. By expanding and differentiating iPS cells, it is possible to generate large numbers of functional neurons in vitro, which can then be used to study the disease of the donating patient. Here, we provide an overview of human stem cell models of neurodegeneration using iPS cells from patients with Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, frontotemporal dementia, Huntington’s disease, spinal muscular atrophy and other neurodegenerative diseases. In addition, we describe how further refinements of reprogramming technology resulted in the generation of patient-specific induced neurons, which have also been used to model neurodegenerative changes in vitro. 相似文献
76.
77.
78.
79.
80.
Tonya White Stefan Ehrlich Beng-Choon Ho Dara S. Manoach Arvind Caprihan S. Charles Schulz Nancy C. Andreasen Randy L. Gollub Vince D. Calhoun Vincent A. Magnotta 《Schizophrenia bulletin》2013,39(5):1077-1086
There is considerable evidence implicating brain white matter (WM) abnormalities in the pathophysiology of schizophrenia; however, the spatial localization of WM abnormalities reported in the existing studies is heterogeneous. Thus, the goal of this study was to quantify the spatial characteristics of WM abnormalities in schizophrenia. One hundred and fourteen patients with schizophrenia and 138 matched controls participated in this multisite study involving the Universities of Iowa, Minnesota, and New Mexico, and the Massachusetts General Hospital. We measured fractional anisotropy (FA) in brain WM regions extracted using 3 different image-processing algorithms: regions of interest, tract-based spatial statistics, and the pothole approach. We found that FA was significantly lower in patients using each of the 3 image-processing algorithms. The region-of-interest approach showed multiple regions with lower FA in patients with schizophrenia, with overlap at all 4 sites in the corpus callosum and posterior thalamic radiation. The tract-based spatial statistic approach showed (1) global differences in 3 of the 4 cohorts and (2) lower frontal FA at the Iowa site. Finally, the pothole approach showed a significantly greater number of WM potholes in patients compared to controls at each of the 4 sites. In conclusion, the spatial characteristics of WM abnormalities in schizophrenia reflect a combination of a global low-level decrease in FA, suggesting a diffuse process, coupled with widely dispersed focal reductions in FA that vary spatially among individuals (ie, potholes).Key words: diffusion tensor imaging, fractional anisotropy, pothole, tract-based spatial statistics 相似文献